Sierra Oncology Reports Positive Results in Pivotal Trial of Momelotinib for Myelofibrosis globalgenes.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globalgenes.org Daily Mail and Mail on Sunday newspapers.
Sierra Oncology has announced topline results of its myelofibrosis treatment, momelotinib, and secured a term loan for commercialization and launch of the treatment
12.12.2021 - Imago BioSciences, Inc. (“Imago”) (Nasdaq: IMGO), a clinical stage biopharmaceutical company discovering new medicines for the treatment of myeloproliferative neoplasms (MPNs), today presented positive data from its ongoing global Phase 2 clinical . Seite 1
- Expanded Phase 2 data set continues to provide compelling rationale for move to registrational clinical program -
- Bomedemstat demonstrated durable clinical improvement in patients with ET who. | December 12, 2021